Dana Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Sell |
2,507
-142
| -5% | -$63.2K | 0.04% | 371 |
|
|
2025
Q1 | $1.28M | Buy |
2,649
+682
| +35% | +$331K | 0.05% | 343 |
|
|
2024
Q4 | $792K | Sell |
1,967
-21
| -1% | -$8.46K | 0.03% | 416 |
|
|
2024
Q3 | $925K | Buy |
1,988
+51
| +3% | +$23.7K | 0.03% | 392 |
|
|
2024
Q2 | $908K | Sell |
1,937
-268
| -12% | -$126K | 0.03% | 386 |
|
|
2024
Q1 | $922K | Hold |
2,205
| – | – | 0.03% | 378 |
|
|
2023
Q4 | $897K | Buy |
+2,205
| New | +$897K | 0.04% | 263 |
|
|
2021
Q1 | – | Sell |
-8,149
| Closed | -$1.93M | – | 341 |
|
|
2020
Q4 | $1.93M | Sell |
8,149
-3,792
| -32% | -$896K | 0.1% | 140 |
|
|
2020
Q3 | $3.25M | Sell |
11,941
-17,886
| -60% | -$4.87M | 0.18% | 94 |
|
|
2020
Q2 | $8.66M | Buy |
29,827
+15,114
| +103% | +$4.39M | 0.47% | 71 |
|
|
2020
Q1 | $3.5M | Buy |
14,713
+1,445
| +11% | +$344K | 0.21% | 78 |
|
|
2019
Q4 | $2.91M | Sell |
13,268
-991
| -7% | -$217K | 0.14% | 98 |
|
|
2019
Q3 | $2.42M | Buy |
14,259
+3,175
| +29% | +$538K | 0.12% | 109 |
|
|
2019
Q2 | $2.03M | Sell |
11,084
-6,487
| -37% | -$1.19M | 0.1% | 148 |
|
|
2019
Q1 | $3.23M | Sell |
17,571
-4,886
| -22% | -$899K | 0.15% | 101 |
|
|
2018
Q4 | $3.72M | Sell |
22,457
-2,476
| -10% | -$410K | 0.19% | 99 |
|
|
2018
Q3 | $4.81M | Buy |
+24,933
| New | +$4.81M | 0.2% | 97 |
|